Role of IL12 as an anti-tumour agent: current status and future directions.
Brunda
M J
MJ
Department of Oncology, Hoffmann-La Roche Inc., Nutley, NJ 07110, USA.
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D018664:Interleukin-12 / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D018664:Interleukin-12